Jan 13, 2026 06:42AM H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)

Jan 12, 2026 07:01AM NovoCure reports $655 million 2025 revenue, up 8% from prior year

Dec 2, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)

Oct 30, 2025 07:05AM Novocure (NVCR) Tops Q3 EPS by 9c

Oct 15, 2025 07:00AM Novocure to present TTFields therapy research at european oncology meetings

Sep 30, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)

Sep 15, 2025 07:02AM NovoCure's Optune Lua receives approval in Japan for lung cancer treatment

Aug 28, 2025 07:18AM Novocure terminates LUNAR-4 lung cancer trial

Aug 25, 2025 07:00AM NovoCure gains health coverage in Spain for glioblastoma therapy

Aug 20, 2025 07:01AM NovoCure submits FDA application for pancreatic cancer treatment

Jul 25, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)

Jul 24, 2025 07:01AM Novocure (NVCR) Tops Q2 EPS by 2c

Jul 8, 2025 07:34AM Ladenburg Thalmann Starts NovoCure Ltd. (NVCR) at Buy

Jul 3, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)

Jun 2, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)

May 30, 2025 08:34AM Piper Sandler Highlights 'Best Value Stocks' in Medical Technology

Apr 25, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)

Apr 24, 2025 07:04AM Novocure (NVCR) Tops Q1 EPS by 18c

Apr 22, 2025 07:12AM Novocure's (NVCR) Optune Lua Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer

Feb 27, 2025 07:06AM Novocure (NVCR) Misses Q4 EPS by 25c

Jan 13, 2025 07:06AM Novocure (NVCR) Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update

Dec 19, 2024 08:17AM Medical Technology and Devices: Piper Sandler Shares 'Quick Thoughts on HC Conference in Jan'

Dec 13, 2024 07:33AM NovoCure Ltd. (NVCR) PT Raised to $42 at Piper Sandler 'Ahead of a New Set of Catalysts in 2025'

Dec 3, 2024 06:44AM NovoCure Ltd. (NVCR) PT Raised to $38 at H.C. Wainwright

Dec 2, 2024 07:03AM Zai Lab Limited (ZLAB) and Novocure (NVCR) Report Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields

Dec 2, 2024 07:01AM Novocure (NVCR) Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields Therapy for Pancreatic Cancer Met Primary Endpoint

Dec 2, 2024 06:00AM Evercore ISI Upgrades NovoCure Ltd. (NVCR) to Outperform 'into Panova readout on asymmetric risk/reward'

Nov 21, 2024 07:01AM Novocure (NVCR): FDA Approves Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma

Oct 31, 2024 07:59AM H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)

Oct 30, 2024 07:12AM Novocure (NVCR) Tops Q3 EPS by 5c

Oct 30, 2024 07:02AM Novocure (NVCR) Appoints Christoph Brackmann as CFO

Oct 16, 2024 06:06AM H.C. Wainwright Upgrades NovoCure Ltd. (NVCR) to Buy

Oct 15, 2024 04:44PM Novocure (NVCR) Announces FDA Approval of Optune Lua for the Treatment of Metastatic Non-Small Cell Lung Cancer

Oct 15, 2024 04:36PM After-hours movers: United Airlines, Interactive Brokers, J.B. Hunt and more

Oct 15, 2024 04:09PM Novocure (NVCR): FDA Approves Optune Lua for the Treatment of Metastatic Non-Small Cell Lung Cancer

Sep 3, 2024 07:01AM Novocure (NVCR) Announces Planned CEO Transition

Jul 26, 2024 06:48AM NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright

Jul 25, 2024 07:02AM Novocure (NVCR) Tops Q2 EPS by 9c